About Beacon Biosignals
Beacon Biosignals is a company based in Boston (United States) founded in 2019 by Jacob Donoghue, Brandon Westover, Jarrett Revels, and Sydney Cash.. Beacon Biosignals has raised $27 million across 1 funding round from investors including General Catalyst, Casdin Capital and Andy Beck. The company has 47 employees as of December 31, 2024. Beacon Biosignals has completed 1 acquisition, including Dreem. Beacon Biosignals offers products and services including Dreem Headband and EEG Neurobiomarker Platform. Beacon Biosignals operates in a competitive market with competitors including Ceribell, BioSerenity, BrainScope, Mynd Analytics and Spark Biomedical, among others.
- Headquarter Boston, United States
- Employees 47 as on 31 Dec, 2024
- Founders Jacob Donoghue, Brandon Westover, Jarrett Revels, Sydney Cash
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Beacon Biosignals, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$27 M (USD)
in 1 rounds
-
Latest Funding Round
$27 M (USD), Series A
Nov 08, 2021
-
Investors
General Catalyst
& 2 more
-
Employee Count
47
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Beacon Biosignals
Beacon Biosignals offers a comprehensive portfolio of products and services, including Dreem Headband and EEG Neurobiomarker Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Wearable device for at-home EEG monitoring in clinical studies.
Platform for EEG data analysis in neurological research and trials.
Unlock access to complete
Funding Insights of Beacon Biosignals
Beacon Biosignals has successfully raised a total of $27M through 1 strategic funding round. The most recent funding activity was a Series A round of $27 million completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $27.0M
-
First Round
First Round
(08 Nov 2021)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2021 | Amount | Series A - Beacon Biosignals | Valuation | General Catalyst |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Beacon Biosignals
Beacon Biosignals has secured backing from 3 investors, including venture fund and angel investors. Prominent investors backing the company include General Catalyst, Casdin Capital and Andy Beck. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment and transformation services for entrepreneurs in technology and finance sectors.
|
Founded Year | Domain | Location | |
|
Investing in Life Sciences sectors like Healthcare and Biotechnology.
|
Founded Year | Domain | Location | |
|
AB
Andy Beck |
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Beacon Biosignals
Beacon Biosignals has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Dreem. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Sleep quality is monitored via Dreem's wearable EEG device.
|
2014 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Beacon Biosignals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Beacon Biosignals Comparisons
Competitors of Beacon Biosignals
Beacon Biosignals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ceribell, BioSerenity, BrainScope, Mynd Analytics and Spark Biomedical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Portable EEG devices for point-of-care seizure diagnosis are provided.
|
|
| domain | founded_year | HQ Location |
Provider of smart healthcare solutions for sleep and EEG lab management
|
|
| domain | founded_year | HQ Location |
Developer of AI-driven EEG platform transforming brain electrical activity into insights
|
|
| domain | founded_year | HQ Location |
Provider of reference data and analytic tools for clinicians and researchers in psychiatry.
|
|
| domain | founded_year | HQ Location |
Neurostimulation devices for opioid withdrawal symptoms are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Beacon Biosignals
Frequently Asked Questions about Beacon Biosignals
When was Beacon Biosignals founded?
Beacon Biosignals was founded in 2019 and raised its 1st funding round 2 years after it was founded.
Where is Beacon Biosignals located?
Beacon Biosignals is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Who is the current CEO of Beacon Biosignals?
Jacob Donoghue is the current CEO of Beacon Biosignals. They have also founded this company.
Is Beacon Biosignals a funded company?
Beacon Biosignals is a funded company, having raised a total of $27M across 1 funding round to date. The company's 1st funding round was a Series A of $27M, raised on Nov 08, 2021.
How many employees does Beacon Biosignals have?
As of Dec 31, 2024, the latest employee count at Beacon Biosignals is 47.
What does Beacon Biosignals do?
Beacon Biosignals was founded in 2019 and is based in Boston, United States. Operations focus on the healthcare sector, where an AI platform for EEG analysis and diagnosis is utilized by professionals. Real-time brain activity is captured to support studies of neurological and psychiatric diseases. Data from the platform is employed to quantify treatment plans and identify suitable patient populations.
Who are the top competitors of Beacon Biosignals?
Beacon Biosignals's top competitors include Ceribell, BrainScope and Spark Biomedical.
What products or services does Beacon Biosignals offer?
Beacon Biosignals offers Dreem Headband and EEG Neurobiomarker Platform.
How many acquisitions has Beacon Biosignals made?
Beacon Biosignals has made 1 acquisition, including Dreem.
Who are Beacon Biosignals's investors?
Beacon Biosignals has 3 investors. Key investors include General Catalyst, Casdin Capital, and Andy Beck.